Cargando…

Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR)

BACKGROUND: Public drug plans are faced with increasingly difficult funding decisions. In Canada, the pan-Canadian Oncology Drug Review (pCODR) makes funding recommendations to the provincial and territorial drug plans responsible for cancer drugs. Assessments of the economic models submitted by pha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masucci, Lisa, Beca, Jaclyn, Sabharwal, Mona, Hoch, Jeffrey S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711746/ https://www.ncbi.nlm.nih.gov/pubmed/29441502 http://dx.doi.org/10.1007/s41669-017-0018-3

Ejemplares similares

Challenges in striving to simultaneously achieve multiple resource allocation goals: the pan-Canadian Oncology Drug Review (pCODR) example
por: McDonald, Heather, et al.
Publicado: (2016)

Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?
por: Hoch, Jeffrey S., et al.
Publicado: (2015)

The CADTH pCODR Expert Review Committee Process Explained. Comment on Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29, 9891–9895
por: Trudeau, Maureen, et al.
Publicado: (2023)

Comparing Manufacturer Submitted and Pan-Canadian Oncology Drug Review Reanalysed Incremental Cost-Effectiveness Ratios for Novel Oncology Drugs
por: Saluja, Ronak, et al.
Publicado: (2021)

Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on “Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29, 9891–9895”
por: Rayson, Daniel, et al.
Publicado: (2023)

CoDR: Correlation-Based Data Reduction Scheme for Efficient Gathering of Heterogeneous Driving Data
por: Park, Junho, et al.
Publicado: (2020)

Pan-Canadian assessment of pandemic immunization data collection: study methodology
por: Pereira, Jennifer A, et al.
Publicado: (2010)

Evolution of health technology assessment: best practices of the pan-Canadian Oncology Drug Review
por: Rocchi, Angela, et al.
Publicado: (2015)

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
por: Chan, Kelvin, et al.
Publicado: (2020)

Economic Evaluation in Stratified Medicine: Methodological Issues and Challenges
por: Fugel, Hans-Joerg, et al.
Publicado: (2016)

State Economic Strength and Some Methodological Issues on Its Assessment
por: Rim, Gwang-Nam, et al.
Publicado: (2020)

Financial conflicts of interest of clinicians making submissions to the pan-Canadian Oncology Drug Review: a descriptive study
por: Lexchin, Joel
Publicado: (2019)

Reporting of harms in oncological clinical study reports submitted to the European Medicines Agency compared to trial registries and publications—a methodological review
por: Paludan-Müller, Asger S., et al.
Publicado: (2021)

Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice
por: O’Mahony, James F., et al.
Publicado: (2015)

Addressing methodological and ethical issues in practicing health economic evaluation in China
por: Jiang, Shan, et al.
Publicado: (2020)

Health economic evaluation of gene replacement therapies: methodological issues and recommendations
por: Aballéa, Samuel, et al.
Publicado: (2020)

Meta-analysis of economic evaluation studies: data harmonisation and methodological issues
por: Bagepally, Bhavani Shankara, et al.
Publicado: (2022)

Economic Evaluation of Digital Health Interventions: Methodological Issues and Recommendations for Practice
por: Gomes, Manuel, et al.
Publicado: (2022)

Sensor and Methodology for Dielectric Analysis of Vegetal Oils Submitted to Thermal Stress
por: Stevan, Sergio Luiz, et al.
Publicado: (2015)

The Relative Importance of Clinical, Economic, Patient Values and Feasibility Criteria in Cancer Drug Reimbursement in Canada: A Revealed Preferences Analysis of Recommendations of the Pan-Canadian Oncology Drug Review 2011–2017
por: Skedgel, Chris, et al.
Publicado: (2018)

FASTING ABBREVIATION AMONG PATIENTS SUBMITTED TO ONCOLOGIC SURGERY: SYSTEMATIC REVIEW
por: PINTO, Andressa dos Santos, et al.
Publicado: (2015)

Convergence Toward the Pan-Canadian Electronic Health Record
por: Richards, Julie, et al.
Publicado: (2005)

Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Analysis and Policy Implications
por: Salek, Sam M., et al.
Publicado: (2019)

Appraisals by Health Technology Assessment Agencies of Economic Evaluations Submitted as Part of Reimbursement Dossiers for Oncology Treatments: Evidence from Canada, the UK, and Australia
por: Ball, Graeme, et al.
Publicado: (2022)

Economic evaluation of smoking cessation in Ontario's regional cancer programs
por: Djalalov, Sandjar, et al.
Publicado: (2018)

EARLY ORAL RE-FEEDING ON ONCOLOGY PATIENTS SUBMITTED TO GASTRECTOMY FOR GASTRIC CANCER
por: LAFFITTE, Andressa Madalozo, et al.
Publicado: (2015)

Statistical recomendations for the authors of manuscripts submitted to the Journal of Cancer Research and Clinical Oncology
por: Ordak, Michal
Publicado: (2022)

Abstract not submitted not submitted for online publication
Publicado: (2011)

Fundamental methodological issues
por: Longbottom, Chris
Publicado: (2023)

Dementia and Diet, Methodological and Statistical Issues: A Pilot Study
por: Stecker, Mark, et al.
Publicado: (2022)

Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal study
por: Perez, Samara, et al.
Publicado: (2016)

Methodological issues in economic evaluations of emergency transport systems in low-income and middle-income countries
por: Lilford, Richard, et al.
Publicado: (2021)

Methodological issues in economic evaluations of disease prevention and health promotion: an overview of systematic and scoping reviews
por: Seleznova, Yana, et al.
Publicado: (2021)

Public health economics: a systematic review of guidance for the economic evaluation of public health interventions and discussion of key methodological issues
por: Edwards, Rhiannon Tudor, et al.
Publicado: (2013)

Integrative practices of Canadian oncology health professionals
por: Brazier, A.S.A., et al.
Publicado: (2008)

Integrative oncology: a Canadian and international perspective
por: Sagar, S.M., et al.
Publicado: (2008)

Canadian Pediatric Neuro-Oncology Standards of Practice
por: Bennett, Julie, et al.
Publicado: (2020)

Developing the first pan-Canadian survey on patient engagement in patient safety
por: Aho-glele, Ursulla, et al.
Publicado: (2021)

The Nascent Pan-Canadian Real-world Health Data Network (PRHDN)
por: Schull, Michael J., et al.
Publicado: (2017)

Pan-Canadian colorectal cancer surgery data: an opportunity for reflection and improvement
por: Moloo, Husein, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c6kfo6mjs05nvdhv1hvptl3h1u